834 related articles for article (PubMed ID: 27500490)
1. ZEB1 drives epithelial-to-mesenchymal transition in lung cancer.
Larsen JE; Nathan V; Osborne JK; Farrow RK; Deb D; Sullivan JP; Dospoy PD; Augustyn A; Hight SK; Sato M; Girard L; Behrens C; Wistuba II; Gazdar AF; Hayward NK; Minna JD
J Clin Invest; 2016 Sep; 126(9):3219-35. PubMed ID: 27500490
[TBL] [Abstract][Full Text] [Related]
2. Decitabine reverses TGF-β1-induced epithelial-mesenchymal transition in non-small-cell lung cancer by regulating miR-200/ZEB axis.
Zhang N; Liu Y; Wang Y; Zhao M; Tu L; Luo F
Drug Des Devel Ther; 2017; 11():969-983. PubMed ID: 28405157
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.
Li C; Wan L; Liu Z; Xu G; Wang S; Su Z; Zhang Y; Zhang C; Liu X; Lei Z; Zhang HT
Cancer Lett; 2018 Apr; 418():185-195. PubMed ID: 29339211
[TBL] [Abstract][Full Text] [Related]
4. ZEB1 induces non-small cell lung cancer development by targeting microRNA-320a to increase the expression of RAD51AP1.
Wang H; Dong H; Qiao L; Wu Y; Wu B; Jin X
Exp Cell Res; 2021 Aug; 405(2):112687. PubMed ID: 34097859
[TBL] [Abstract][Full Text] [Related]
5. BENC-511, a novel PI3K inhibitor, suppresses metastasis of non-small cell lung cancer cells by modulating β-catenin/ZEB1 regulatory loop.
Zhang Q; Zhou L; Guan Y; Cheng Y; Han X
Chem Biol Interact; 2018 Oct; 294():18-27. PubMed ID: 30125547
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-induced HIF-1α and ZEB1 are critical for the malignant transformation of ameloblastoma via TGF-β-dependent EMT.
Yoshimoto S; Tanaka F; Morita H; Hiraki A; Hashimoto S
Cancer Med; 2019 Dec; 8(18):7822-7832. PubMed ID: 31674718
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
[TBL] [Abstract][Full Text] [Related]
8. TGFβ mediated LINC00273 upregulation sponges mir200a-3p and promotes invasion and metastasis by activating ZEB1.
Sarkar A; Rahaman A; Biswas I; Mukherjee G; Chatterjee S; Bhattacharjee S; Mandal DP
J Cell Physiol; 2020 Oct; 235(10):7159-7172. PubMed ID: 32017082
[TBL] [Abstract][Full Text] [Related]
9. PTBP3-Mediated Regulation of ZEB1 mRNA Stability Promotes Epithelial-Mesenchymal Transition in Breast Cancer.
Hou P; Li L; Chen F; Chen Y; Liu H; Li J; Bai J; Zheng J
Cancer Res; 2018 Jan; 78(2):387-398. PubMed ID: 29187406
[TBL] [Abstract][Full Text] [Related]
10. Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.
Zhao L; Li X; Song N; Li A; Hou K; Qu X; Che X; Liu Y
Cell Biol Int; 2018 Mar; 42(3):294-302. PubMed ID: 29052277
[TBL] [Abstract][Full Text] [Related]
11. LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression.
Liang H; Yu T; Han Y; Jiang H; Wang C; You T; Zhao X; Shan H; Yang R; Yang L; Shan H; Gu Y
Mol Cancer; 2018 Aug; 17(1):119. PubMed ID: 30098599
[TBL] [Abstract][Full Text] [Related]
12. Thymidylate synthase is functionally associated with ZEB1 and contributes to the epithelial-to-mesenchymal transition of cancer cells.
Siddiqui A; Vazakidou ME; Schwab A; Napoli F; Fernandez-Molina C; Rapa I; Stemmler MP; Volante M; Brabletz T; Ceppi P
J Pathol; 2017 Jun; 242(2):221-233. PubMed ID: 28337746
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
[No Abstract] [Full Text] [Related]
14. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling.
Dai Y; Wu Z; Lang C; Zhang X; He S; Yang Q; Guo W; Lai Y; Du H; Peng X; Ren D
Theranostics; 2019; 9(21):6063-6079. PubMed ID: 31534537
[No Abstract] [Full Text] [Related]
15. Long non-coding ribonucleic acid zinc finger antisense 1 promotes the progression of colonic cancer by modulating ZEB1 expression.
Fang C; Zan J; Yue B; Liu C; He C; Yan D
J Gastroenterol Hepatol; 2017 Jun; 32(6):1204-1211. PubMed ID: 27862275
[TBL] [Abstract][Full Text] [Related]
16. Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer.
Liu M; Zhang Y; Yang J; Zhan H; Zhou Z; Jiang Y; Shi X; Fan X; Zhang J; Luo W; Fung KA; Xu C; Bronze MS; Houchen CW; Li M
Gastroenterology; 2021 Apr; 160(5):1771-1783.e1. PubMed ID: 33421513
[TBL] [Abstract][Full Text] [Related]
17. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J
Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012
[TBL] [Abstract][Full Text] [Related]
18. PARP-1 induces EMT in non-small cell lung carcinoma cells via modulating the transcription factors Smad4, p65 and ZEB1.
Kumar M; Jaiswal RK; Prasad R; Yadav SS; Kumar A; Yadava PK; Singh RP
Life Sci; 2021 Mar; 269():118994. PubMed ID: 33417952
[TBL] [Abstract][Full Text] [Related]
19. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD
J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1.
Voena C; Varesio LM; Zhang L; Menotti M; Poggio T; Panizza E; Wang Q; Minero VG; Fagoonee S; Compagno M; Altruda F; Monti S; Chiarle R
Oncotarget; 2016 May; 7(22):33316-30. PubMed ID: 27119231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]